Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00784758 · ClinicalTrials.gov registry record · NA
Fenzian Asthma Multicenter Outcomes Study
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT00784758 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 81 participants.
The verdict
NCT00784758, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of Fenzian™ treatment on symptoms (such as shortness of breath), lung function (how well the lungs work), and albuterol/salbutamol (rescue medication) use in people with asthma. This will be done by comparing the effects of Fenzian™ treatment to the effects of a sham treatment, which looks the same as the Fenzian™ device but doesn't do anything. The Fenzian™ device is an electrical instrument that the investigators hope will help reduce airway inflammation associated with asthma symptoms by stimulating the nerves with very low electrical currents. The study device will be applied directly to the skin on the back, working along the ribs toward the spine, alternating between left and right sides, and on your face.
Interventions
- DEVICE Sham Device
- DEVICE Fenzian Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00784758
The ClinicalTrials.gov registry entry for NCT00784758 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Device is the first listed.
NCT00784758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00784758 about?
NCT00784758 is a clinical study titled "Fenzian Asthma Multicenter Outcomes Study". The purpose of this study is to investigate the effects of Fenzian™ treatment on symptoms (such as shortness of breath), lung function (how well the lungs work), and albuterol/salbutamol (rescue medication) use in people with asthma. This will be done by comparing the effects of Fenzian™ treatment t...
What is the current status of trial NCT00784758?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2009-02. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00784758?
The interventions under investigation include: Sham Device (DEVICE), Fenzian Device (DEVICE).
Who is sponsoring clinical trial NCT00784758?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.